Results 1 to 10 of about 92,970 (328)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast

open access: goldClinics, 2013
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ductal carcinoma in situ of the breast. METHODS: One hundred and twenty-one cases of high-grade ductal carcinoma in situ, pure or associated with invasive
Amanda Arantes Perez   +4 more
doaj   +2 more sources

DUCTAL CARCINOMA IN SITU

open access: yesEuropean Journal of Breast Health, 2010
Atilla Soran
doaj   +3 more sources

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast

open access: yesJournal of Pathology of Nepal, 2023
Background: The clinical outcome of breast carcinoma varies in each individual due to its molecular heterogeneity. There is a rising interest in whether the associated ductal carcinoma in-situ in invasive ductal carcinoma of breast affects the prognosis ...
Dhivya Balaiya   +2 more
doaj   +1 more source

Immunohistochemical Expression of p63 in Benign and Malignant Breast Lesions [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Breast carcinoma demands attention as it causes high morbidity and mortality. It is important to recognise benign lesions to distinguish them from in situ and invasive breast cancer and to assess a patient’s risk of developing breast ...
Abhishek Saini   +6 more
doaj   +1 more source

Breast Ductal Carcinoma In Situ [PDF]

open access: yesInternational Journal of Surgical Oncology, 2012
Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
V. Sacchini   +5 more
openaire   +2 more sources

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report

open access: yes대한영상의학회지, 2022
The incidence of ductal carcinoma in situ has increased with the rise in screening mammography; currently, ductal carcinoma in situ constitutes 20%–25% of all breast cancers, and up to half of them may become invasive.
Yeon Jung Kim, Hyun Kyung Jung, Woogyeong Kim
doaj   +1 more source

Profile of Digital Mammography Findings in Patients with Histopathologically Proven Ductal Carcinoma in Situ (DCIS)

open access: yesGalician Medical Journal, 2020
Breast carcinoma is a heterogeneous group of tumors with a wide spectrum of clinical presentations, lesion characterization and diagnostic evaluation.
Ankit Prabhakar   +4 more
doaj   +1 more source

A Case of Pleomorphic Adenoma and Ductal Carcinoma In Situ in the Same Mammary Gland. [PDF]

open access: goldSurg Case Rep
Nagasawa S   +15 more
europepmc   +3 more sources

Potential biomarkers of ductal carcinoma in situ progression

open access: yesBMC Cancer, 2020
Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
Raquel Spinassé Dettogni   +17 more
doaj   +1 more source

The shifting nature of women’s experiences and perceptions of ductal carcinoma in situ [PDF]

open access: yes, 2011
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to one year later.
Baum   +51 more
core   +1 more source

Home - About - Disclaimer - Privacy